Search

Author/Creator Lugaresi, A.

1. Anti‐inflammatory disease‐modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study. (2nd November 2018)

Authors:
Lorscheider, J.; Kuhle, J.; Izquierdo, G.; Lugaresi, A.; Havrdova, E.; Horakova, D.; Hupperts, R.; Duquette, P.; Girard, M.; Prat, A.; Grand'Maison, F.; Grammond, P.; Sola, P.; Ferraro, D.; Trojano, M.; Ramo‐Tello, C.; Lechner‐Scott, J.; Pucci, E.; Solaro, C.; Slee, M.
Journal:
European journal of neurology
Issue:
Volume 26:Number 2(2019)
Page Start:
363
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. BREMSO: a simple score to predict early the natural course of multiple sclerosis. (25th March 2015)

Authors:
Bergamaschi, R.; Montomoli, C.; Mallucci, G.; Lugaresi, A.; Izquierdo, G.; Grand'Maison, F.; Duquette, P.; Shaygannejad, V.; Alroughani, R.; Grammond, P.; Boz, C.; Iuliano, G.; Zwanikken, C.; Petersen, T.; Lechner‐Scott, J.; Hupperts, R.; Butzkueven, H.; Pucci, E.; Oreja‐Guevara, C.; Cristiano, E.
Journal:
European journal of neurology
Issue:
Volume 22:Number 6(2015:Jun.)
Page Start:
981
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Dimethyl fumarate‐induced lymphocyte count drop is related to clinical effectiveness in relapsing–remitting multiple sclerosis. (17th October 2020)

Authors:
Tsantes, E.; Curti, E.; Ferraro, D.; Lugaresi, A.; Baldi, E.; Montepietra, S.; Immovilli, P.; Simone, A. M.; Mancinelli, L.; Strumia, S.; Vitetta, F.; Foschi, M.; Ferri, C.; Ferrarini, C.; Sola, P.; Granella, F.
Journal:
European journal of neurology
Issue:
Volume 28:Number 1(2021)
Page Start:
269
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Erratum to: 'Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial'. Issue 1 (December 2016)

Authors:
Solari, A.; Giordano, A.; Grasso, M.; Confalonieri, P.; Patti, F.; Lugaresi, A.; Palmisano, L.; Amadeo, R.; Martino, G.; Ponzio, M.; Casale, G.; Borreani, C.; Causarano, R.; Veronese, S.; Zaratin, P.; Battaglia, M.
Journal:
Trials
Issue:
Volume 17:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis. (19th January 2016)

Authors:
Spelman, T.; Mekhael, L.; Burke, T.; Butzkueven, H.; Hodgkinson, S.; Havrdova, E.; Horakova, D.; Duquette, P.; Izquierdo, G.; Grand'Maison, F.; Grammond, P.; Barnett, M.; Lechner‐Scott, J.; Alroughani, R.; Trojano, M.; Lugaresi, A.; Granella, F.; Pucci, E.; Vucic, S.
Journal:
European journal of neurology
Issue:
Volume 23:Number 4(2016:Apr.)
Page Start:
729
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗